Scroll for more


Sep 20, 2018 upcoming events

2nd Annual Artificial Intelligence in Drug Development Congress

This September, Marc Davies, VP Biomedical Informatics will be presenting at the Artificial Intelligence in Drug Development Congress on how machine learning technologies are changing how new medicines are discovered and developed. 

Jul 10, 2018 upcoming events

ON Helix

Join Mark Rackam at ON Helix event in Cambridge where he will be presenting "When the Rubber Hits the Road: A Case Study of AI applied to ALS Drug Discovery"

Jun 7, 2018 previous

19th Annual Drug Discovery Summit

Join Nathan Brown, Head of Chemoinformatics at BenevolentAI at the 19th Annual Drug Discovery Summit and 6th Annual Discovery Chemistry and Drug Design Congress.

Apr 24, 2018 previous

Codex - International Technology Leaders Network

This is a timely event which will examine the unprecedented disruption and transformation of industries, business and the jobs market due to advancements in Artificial Intelligence and Virtual and Augmented Reality.

Apr 23, 2018 previous

World Medical Innovation Forum

Join Jackie Hunter, CEO BenevolentBio along with AI in Healthcare leaders to discuss the latest innovation in healthcare

Apr 17, 2018 previous

Research & Innovation 2018

Join world class speakers and our VP Drug discovery to discuss the challenges and opportunities in the area of new technologies and novel targets to improve the success of drug discovery

Mar 21, 2018 previous

Annual Conference on Drug Discovery

This conference will bring together key opinion leaders and senior industry experts to discuss the latest developments in drug discovery strategies, included Mark Davies, VP Bioinformatics at BenevolentAI.

Mar 13, 2018 previous

WIRED Health

Meet Jackie Hunter, CEO BenevolentBio and more than 500 healthcare, pharmaceutical and technology influencers and leaders at the fifth annual WIRED Health event in London.

Mar 6, 2018 previous

NIHR Northern Biomedical Research Centres' showcase

Join Mark Rackham, Drug discovery scientist at BenevolentAI for a panel discussion on Precision Medicine and Biomarker Discovery

Feb 21, 2018 previous

Artificial Intelligence Transforming Pharma R&D

In 2016, total expenditure on prescription drugs in the US was estimated at $450 billion. During this year, almost half of the US population took at least one prescription medicine every month. It is essential that we find ways to streamline this process, removing inefficencies and unnecessary costs, while bringing efficacious prescription drugs to the population as soon as possible. We believe that Artificial Intelligence offers the best solutions to solve these issues.

Jan 30, 2018 previous

Advanced Pharma Analytics Europe Summit 2018

The 5th annual Advanced Pharma Analytics Europe Summit 2018 is dedicated to bringing together Data Science and Advanced Analytics leaders to address the biggest challenges and opportunities in this space.

Jan 25, 2018 previous

Webinar | A New Strategy in Drug Discovery: Protac-Induced Protein Degradation

Join Ian Churcher, VP of Drug Discovery at BenevolentBio as he discusses Targeted Protein Degradation, one of the most exciting and fast growing areas of drug discovery. Ian will give an introduction to the area and highlight how AI approaches can be used to accelerate progress.

Jan 10, 2018 previous

JP Morgan Healthcare Conference 2018

Jackie Hunter, CEO BenevolentAI is presenting at JP Morgan Healthcare Conference on the future of Pharma.

Dec 13, 2017 previous

Future Physiology: Development for Ageing

Join Jackie Hunter, CEO BenevolentBio who will share her thoughts and her experience.

Dec 6, 2017 previous

Healthcare of the future, Medical Innovations

Join Mark Davies, VP Biomedical Informatics at BenevolentAI for a talk on "Disrupting Drug Discovery with AI"

Nov 18, 2017 previous

SpotOn 17

Join Rabia T. Khan, Exploratory Scientist at BenevolentAI for a panel discussion on What makes a great researcher: tools and skills.

Nov 15, 2017 previous

Pharma Integrates 2017

Join Patrick Keohane, CMO at BenevolentAI for a panel on Disruption from Afar: Embracing New Non-Pharma Technologies & Actors

Nov 6, 2017 previous

Web Summit

Jackie Hunter, CEO BenevolentBio and Jerome Pesenti, CEO BenevolentTech will be joining Web Summit this year.

Nov 2, 2017 previous

BioData World Congress 2017

Patrick Keohane, Chied Medical Officer at BenevolentBio will be presenting at the BioData World Congress 2017

Oct 16, 2017 previous

Data Driven NYC #58

Jerome Pesenti, CEO at BenevolentTech will be joining Data Driven Event held at Bloomberg LP to discuss how BenevolentAI artificial intelligence can accelerate drug discovery

Oct 11, 2017 previous

What can Big Data do for Chemistry?

Big Data is the process of analysing high volume, high velocity data by advanced computational methods that produce actionable knowledge...

Aug 21, 2017 previous

London Machine Learning Meet-up

Amir Saffari, Director of Applied AI will be discussing Machine Learning for Drug Discovery - Join the event

Jul 13, 2017 previous

On Helix One Nucleus

Translating UK scientific excellence in global therapeutics strategies

Jun 15, 2017 previous

Viva Technology

Meet Jérôme Pesenti, CEO BenevolentTech at Viva Technology in Paris